A Win For VBI Vaccines Inc.
Fri, Jun 30, 2023 at 07:58 PM
VBI Vaccines Inc. (VBIV:NASDAQ) jumped higher at $3.29, representing a gain of 75%. On Fri, Jun 30, 2023, VBIV:NASDAQ touched a New 2-Week High of $3.29. The stock got featured on our News Catalysts scanner on Fri, Jun 23, 2023 at 04:35 PM in the 'BIOTECH' category. From Fri, Jun 16, 2023, the stock recorded 44.44% Up Days and 30.00% Green Days
About VBI Vaccines Inc. (VBIV:NASDAQ)
VBI Vaccines Inc is a biopharmaceutical company. It is engaged in developing novel technologies that seek to expand vaccine protection in large underserved markets.
Top 10 Gainers:
- Viveve Medical, Inc. (VIVE:NASDAQ), 2900%
- Baudax Bio, Inc. (BXRX:NASDAQ), 124.91%
- VBI Vaccines Inc. (VBIV:NASDAQ), 75%
- Renalytix AI plc (RNLX:NASDAQ), 43.84%
- CymaBay Therapeutics, Inc. (CBAY:NASDAQ), 39.67%
- Rackspace Technology Inc. (RXT:NASDAQ), 38.78%
- Cyteir Therapeutics Inc. (CYT:NASDAQ), 35.42%
- Eiger BioPharmaceuticals, Inc. (EIGR:NASDAQ), 27.98%
- PainReform Ltd. (PRFX:NASDAQ), 27.06%
- Gracell Biotechnologies Inc. (GRCL:NASDAQ), 27%